ºÚÁϳԹÏ×ÊÔ´

PÃ¥l Rasmus Njølstad, MD PhD, Njølstad´s is interested in childhood and monogenic diabetes having described new diabetes syndromes including diabetes and exocrine dysfunction due to mutations in CEL, and found that neonatal diabetes can be treated with sulfonylurea tablets instead of insulin. Njølstad is Professor and Head of Department of Clinical Medicine, University of Bergen, Consultant Physician at the Department of Pediatrics, Haukeland University Hospital, and Leader of Center for Diabetes Research coordinating a proposal for a Norwegian center of excellence, Center for Diabetes Mechanisms. He has had research stays at the University of Chicago, Harvard Medical School, Broad Institute of Harvard and MIT, and Massachusetts General Hospital. He has achieved competitive research funding, eg. from the European Research Council (ERC AdG) and the Novo Nordisk Foundation, has earned several international prizes, and is member of the Norwegian Society of Science and Letters.